MODULATION OF OXIDATIVE STRESS INDUCED APOPTOSIS AND AUTOPHAGY IN CARDIOMYOCYTES BY INTERMEDIN

The heart is subjected to oxidative stress in conditions of increased reactive oxygen species (ROS) production, such as doxorubicin (DOX) chemotherapy. A major cause of associated ventricular dysfunction is cardiomyocyte loss through apoptosis, while autophagic processes can also be detrimental. Int...

Full description

Saved in:
Bibliographic Details
Published inHeart (British Cardiac Society) Vol. 98; no. Suppl 5; pp. A9 - A10
Main Authors McCarthy, C, Zhao, Y, McKeag, P, Treggiari, D, McLaughlin, D, Colhoun, L, Grieve, D J, McDermott, B J
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd and British Cardiovascular Society 01.11.2012
BMJ Publishing Group LTD
Online AccessGet full text

Cover

Loading…
Abstract The heart is subjected to oxidative stress in conditions of increased reactive oxygen species (ROS) production, such as doxorubicin (DOX) chemotherapy. A major cause of associated ventricular dysfunction is cardiomyocyte loss through apoptosis, while autophagic processes can also be detrimental. Intermedin (IMD) has emerged as a major counter-regulatory peptide with cytoprotective properties. Here we examined its potential to be upregulated and attenuate indices of cardiomyocyte death by a mechanism involving NADPH oxidase-derived superoxide. In isolated adult C57BL/6J wild type (WT) mouse ventricular cardiomyocytes, DOX (5×10−7 M) increased preproIMD mRNA expression 3.5-fold, which was significantly decreased in NOX2-deficient cells. Similarly, IMD mRNA was upregulated by the direct pro-oxidant, H2O2 (10−7 M) in both WT and HL-1 cardiomyocytes, as was NOX2; DOX increased IMD protein (immuno-cytochemistry). Superoxide production stimulated by DOX or H2O2 (by ∼35%, lucigenin-enhanced chemiluminescence), was abolished by IMD (10−10 M–10−8 M) in both WT and HL-1 cardiomyocytes. Apoptosis in HL-1 cells, shown by DOX-induced increases in caspase 3/7 activity (3.5-fold), was decreased significantly by IMD (10−9 M), which also increased cell viability. Increased autophagosome formation after serum starvation or DOX treatment (by ∼50%, Cyto-ID fusion with LC3 protein), was decreased to control values by IMD (10−9 M). Confocal imaging showed numerous cytoplasmic punctate structures with DOX, whereas addition of IMD showed a diffuse LC-3 staining pattern similar to control. These findings indicate that a NOX2-mediated increase in IMD in cardiomyocytes could have a potential autocrine effect, acting at nM concentration to reduce levels of superoxide and so limit cell death by apoptotic and autophagic mechanisms.
AbstractList The heart is subjected to oxidative stress in conditions of increased reactive oxygen species (ROS) production, such as doxorubicin (DOX) chemotherapy. A major cause of associated ventricular dysfunction is cardiomyocyte loss through apoptosis, while autophagic processes can also be detrimental. Intermedin (IMD) has emerged as a major counter-regulatory peptide with cytoprotective properties. Here we examined its potential to be upregulated and attenuate indices of cardiomyocyte death by a mechanism involving NADPH oxidase-derived superoxide. In isolated adult C57BL/6J wild type (WT) mouse ventricular cardiomyocytes, DOX (5×10−7 M) increased preproIMD mRNA expression 3.5-fold, which was significantly decreased in NOX2-deficient cells. Similarly, IMD mRNA was upregulated by the direct pro-oxidant, H2O2 (10−7 M) in both WT and HL-1 cardiomyocytes, as was NOX2; DOX increased IMD protein (immuno-cytochemistry). Superoxide production stimulated by DOX or H2O2 (by ∼35%, lucigenin-enhanced chemiluminescence), was abolished by IMD (10−10 M–10−8 M) in both WT and HL-1 cardiomyocytes. Apoptosis in HL-1 cells, shown by DOX-induced increases in caspase 3/7 activity (3.5-fold), was decreased significantly by IMD (10−9 M), which also increased cell viability. Increased autophagosome formation after serum starvation or DOX treatment (by ∼50%, Cyto-ID fusion with LC3 protein), was decreased to control values by IMD (10−9 M). Confocal imaging showed numerous cytoplasmic punctate structures with DOX, whereas addition of IMD showed a diffuse LC-3 staining pattern similar to control. These findings indicate that a NOX2-mediated increase in IMD in cardiomyocytes could have a potential autocrine effect, acting at nM concentration to reduce levels of superoxide and so limit cell death by apoptotic and autophagic mechanisms.
The heart is subjected to oxidative stress in conditions of increased reactive oxygen species (ROS) production, such as doxorubicin (DOX) chemotherapy. A major cause of associated ventricular dysfunction is cardiomyocyte loss through apoptosis, while autophagic processes can also be detrimental. Intermedin (IMD) has emerged as a major counter-regulatory peptide with cytoprotective properties. Here we examined its potential to be upregulated and attenuate indices of cardiomyocyte death by a mechanism involving NADPH oxidase-derived superoxide. In isolated adult C57BL/6J wild type (WT) mouse ventricular cardiomyocytes, DOX (5x10-7 M) increased preproIMD mRNA expression 3.5-fold, which was significantly decreased in NOX2-deficient cells. Similarly, IMD mRNA was upregulated by the direct pro-oxidant, H2 O2 (10-7 M) in both WT and HL-1 cardiomyocytes, as was NOX2; DOX increased IMD protein (immuno-cytochemistry). Superoxide production stimulated by DOX or H2 O2 (by ∼35%, lucigenin-enhanced chemiluminescence), was abolished by IMD (10-10 M-10-8 M) in both WT and HL-1 cardiomyocytes. Apoptosis in HL-1 cells, shown by DOX-induced increases in caspase 3/7 activity (3.5-fold), was decreased significantly by IMD (10-9 M), which also increased cell viability. Increased autophagosome formation after serum starvation or DOX treatment (by ∼50%, Cyto-ID fusion with LC3 protein), was decreased to control values by IMD (10-9 M). Confocal imaging showed numerous cytoplasmic punctate structures with DOX, whereas addition of IMD showed a diffuse LC-3 staining pattern similar to control. These findings indicate that a NOX2-mediated increase in IMD in cardiomyocytes could have a potential autocrine effect, acting at nM concentration to reduce levels of superoxide and so limit cell death by apoptotic and autophagic mechanisms.
Author Colhoun, L
Treggiari, D
McLaughlin, D
McKeag, P
Grieve, D J
Zhao, Y
McCarthy, C
McDermott, B J
Author_xml – sequence: 1
  givenname: C
  surname: McCarthy
  fullname: McCarthy, C
– sequence: 2
  givenname: Y
  surname: Zhao
  fullname: Zhao, Y
– sequence: 3
  givenname: P
  surname: McKeag
  fullname: McKeag, P
– sequence: 4
  givenname: D
  surname: Treggiari
  fullname: Treggiari, D
– sequence: 5
  givenname: D
  surname: McLaughlin
  fullname: McLaughlin, D
– sequence: 6
  givenname: L
  surname: Colhoun
  fullname: Colhoun, L
– sequence: 7
  givenname: D J
  surname: Grieve
  fullname: Grieve, D J
– sequence: 8
  givenname: B J
  surname: McDermott
  fullname: McDermott, B J
BookMark eNqNUE1PwkAU3BhNBPQ_bOK5uB_92B5LW6ARukgLgYubbbtEECi2kOi_d5uiZ0_vzbyZN8l0we2xPCoAIEZ9jKn9_K5kdd4d9wZBmBgUUWwy2SfuDehg02YNvbrVO7Usw0bUuQfdut4hhEyX2R3wNuXBYuKlEY8hH0K-igINliFM0nmYJDCKg4UfBtCb8VnKkyiBXqzRIuWzsTda6zv0vXkQ8ema--s0TOCgIdNwPg2DKH4Adxu5r9XjdfbAYhim_tiY8FHkexMjI8h1DRNtpLkp8gwTF0kb48LFeU6KTErGTNc2M5TnuW1pSDVyFC1w7jiK0EJJlhHaA0_t31NVfl5UfRa78lIddaTADkMOsbDZqFiryquyriu1Eadqe5DVt8BING2K3zZF06a4timIq61Ga93WZ_X155PVh7Ad6lgiXvri5XU2XJKEiIHW01afHXb_T_kBtniEjg
ContentType Journal Article
Copyright Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright_xml – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
DBID BSCLL
AAYXX
CITATION
3V.
7X7
7XB
88E
88I
8AF
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
M0S
M1P
M2P
PQEST
PQQKQ
PQUKI
PRINS
Q9U
DOI 10.1136/heartjnl-2012-303148a.29
DatabaseName Istex
CrossRef
ProQuest Central (Corporate)
Health & Medical Complete (ProQuest Database)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
BMJ Journals
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Science Journals
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
DatabaseTitle CrossRef
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList

ProQuest Central Student
Database_xml – sequence: 1
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-201X
EndPage A10
ExternalDocumentID 4021053341
10_1136_heartjnl_2012_303148a_29
ark_67375_NVC_KQPFV2S2_B
GroupedDBID ---
.55
.VT
0R~
29I
2WC
354
39C
3O-
3V.
4.4
40O
53G
5GY
5RE
7X7
7~S
88E
88I
8AF
8FI
8FJ
8R4
8R5
AAFWJ
AAHLL
AAKAS
AAOJX
AAWJN
AAWTL
AAYEP
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABUWG
ABVAJ
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACOFX
ACTZY
ADBBV
ADCEG
ADUGQ
ADZCM
AEKJL
AENEX
AFFNX
AFKRA
AFWFF
AHMBA
AHNKE
AHQMW
AJYBZ
AKKEP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZFZN
AZQEC
BAWUL
BCR
BENPR
BLC
BLJBA
BOMFT
BPHCQ
BTHHO
BVXVI
C1A
CAG
CCPQU
COF
CXRWF
DIK
DU5
DWQXO
E3Z
EBS
EJD
EX3
F5P
FEDTE
FYUFA
GNUQQ
GX1
H13
HAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IHR
INH
INR
IOF
ITC
J5H
L7B
M1P
M2P
N4W
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PCD
PEA
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
TEORI
TR2
UKHRP
UYXKK
V24
VM9
WH7
WOQ
WOW
X7M
YFH
YQY
ZGI
ZXP
BSCLL
AAYXX
CITATION
7XB
8FK
K9.
PQEST
PQUKI
PRINS
Q9U
ID FETCH-LOGICAL-b2099-40fa4fdcb1290a611d91cc2dbaa884964b0ccc65aa839647e3d1c77e23dea8b23
IEDL.DBID 7X7
ISSN 1355-6037
IngestDate Thu Oct 10 17:38:45 EDT 2024
Fri Aug 23 02:31:50 EDT 2024
Wed Oct 30 09:38:05 EDT 2024
Wed Aug 21 02:05:40 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Suppl 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b2099-40fa4fdcb1290a611d91cc2dbaa884964b0ccc65aa839647e3d1c77e23dea8b23
Notes istex:2FD4BF74CFF0F80EF5CFC477B3EED6DFF63A525E
href:heartjnl-98-A9-4.pdf
local:heartjnl;98/Suppl_5/A9-d
ark:/67375/NVC-KQPFV2S2-B
OpenAccessLink https://heart.bmj.com/content/heartjnl/98/Suppl_5/A9.4.full.pdf
PQID 1780725142
PQPubID 2041068
ParticipantIDs proquest_journals_1780725142
crossref_primary_10_1136_heartjnl_2012_303148a_29
istex_primary_ark_67375_NVC_KQPFV2S2_B
bmj_primary_10_1136_heartjnl_2012_303148a_29
PublicationCentury 2000
PublicationDate 20121100
2012-11
2012-11-00
20121101
PublicationDateYYYYMMDD 2012-11-01
PublicationDate_xml – month: 11
  year: 2012
  text: 20121100
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Heart (British Cardiac Society)
PublicationTitleAlternate Heart
PublicationYear 2012
Publisher BMJ Publishing Group Ltd and British Cardiovascular Society
BMJ Publishing Group LTD
Publisher_xml – name: BMJ Publishing Group Ltd and British Cardiovascular Society
– name: BMJ Publishing Group LTD
SSID ssj0004986
Score 2.0821915
Snippet The heart is subjected to oxidative stress in conditions of increased reactive oxygen species (ROS) production, such as doxorubicin (DOX) chemotherapy. A major...
SourceID proquest
crossref
istex
bmj
SourceType Aggregation Database
Publisher
StartPage A9
Title MODULATION OF OXIDATIVE STRESS INDUCED APOPTOSIS AND AUTOPHAGY IN CARDIOMYOCYTES BY INTERMEDIN
URI http://dx.doi.org/10.1136/heartjnl-2012-303148a.29
https://api.istex.fr/ark:/67375/NVC-KQPFV2S2-B/fulltext.pdf
https://www.proquest.com/docview/1780725142
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFLfYKiEuE5-iY5t8QJwIS2LHTk4oTVJaoElYkqq9zLId9zCgG1uR9ufjlyVMCAmJ44vlHH5-fl9-Hwi9JspIQjfc4ZZhHBoR5UgdUMdVTGtlotBzod55kbNZQz-uglUfcLvp0yoHmdgJ6vZSQ4z81OOhy60ypv77qx8OTI2C19V-hMYeGnm-y4Cr-Yrf10VG3aRHz-pUh7mED5k8hJ3CuOjdxfab5RLo2gdN3EP5DgzNPfX94g8lNQK8b_-S1Z0Cmj5GB73liOO7o36CHpjtU_Rw0b-NP0PniyJtPnchJ1xMcbGap5ZYZriqAWU8z9MmyVIcl0VZF9W8wnFuqaYuyln8YW3XcRKfpfNisS6SdZ1VeAIfrbkLLSDz56iZZnUyc_rpCY6CcljrGG4k3bRaQaRJMs9rI09rv1VShiGNGFWu1poFliRQjmpI62nOjU9aI0Plkxdof3u5NS8RZoEKXOPaXxFKDThZRCu9oYa7vlFtOEZvLWji6q4_huj8CsLEgLEAjEWPsfCjMfIGdP9jz5vuGH5vkNdfISeNByJfJuLTl3K69CtfTMboaDgn0V_HG3HPPIf_Xn6FHnUM0RUbHqH93fVPc2ytjp066VjrBI0mWV6e_QK5k8ym
link.rule.ids 315,783,787,12069,21401,27937,27938,31732,33757,43323,43818,74080,74637
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFLfYJgGXiU9RtoEPiBNhSezYyQllSUvDmqSQpGovs2zHPQzoxlYk_vz5ZQkTQkLi-GI5h5-f35ffB0JviDKS0DV3uGUYh0ZEOVIH1HEV01qZKPRcqHfOCzZt6KdlsOwDbtd9WuUgEztB3V5oiJEfezx0uVXG1P9w-cOBqVHwutqP0NhBe9CHC_icL_ldXWTUTXr0rE51mEv4kMlD2DGMi96eb75ZLoGufdDEPZTvwdDcUd_P_1BSe4D3r79kdaeAJo_Qfm854vj2qB-je2bzBN3P-7fxp-gsL9Nm1oWccDnB5TJLLbEY46oGlHFWpE0yTnE8L-d1WWUVjgtLNXU5n8YfV3YdJ_GXNCvzVZms6nGFT-CjNXehBWTxDDWTcZ1MnX56gqOgHNY6hmtJ161WEGmSzPPayNPab5WUYUgjRpWrtWaBJQmUoxrSeppz45PWyFD55Dna3VxszAuEWaAC17j2V4RSA04W0UqvqeGub1QbjtA7C5q4vO2PITq_gjAxYCwAY9FjLPxohLwB3f_Y87Y7ht8b5NVXyEnjgSgWiTj9PJ8s_MoXJyN0OJyT6K_jtbhjnpf_Xn6NHkzrfCZmWXF6gB52zNEVHh6i3e3VT3NkLZCtetWx2Q37qc3z
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Lb9MwGLfYKk1c0HiJwgAfECdCk9ixkxNK86BhaxKWpGovWLHjHAbrxlak_fmzM4cJISFx_GI5h58_fy9_DwDeIS5bhHtqUcUwFg4Qt1rhYcvmRAguA9-xdb3zMieLBn9Ze2uT_3Rt0ipHmTgI6u5C6Bj5zKG-TZUyxu6sN2kRZZx-uvxp6QlS-qXVjNPYAxOKCVKO2GSe5OXpfZVkMMx9dJSGtYiN6JjXg8hMD4_enW1_KJ7RPfx0S3e__ajNzj1-fvaHyppo9G_-ktyDOkoPwSNjR8Lw7uAfgwdy-wQcLM1L-VPwbVnEzckQgIJFCot1FitilcCq1pjDLI-bKIlhWBZlXVRZBcNcUU1dlIvw80atwyg8jbNiuSmiTZ1UcK4_KuNXN4TMn4EmTepoYZlZChbXxbHKTexb3HeC67hTSxynCxwh3I63re_jgGBuCyGIp0iki1Ml6hxBqXRRJ1ufu-g52N9ebOULAInHPVva6lcIY6ldLiS46LGktit550_BBwUau7zrlsEGLwMRNmLMNMbMYMzcYAqcEd3_2PN-OIbfG9qr7zpDjXosX0Xs-GuZrtzKZfMpOBrPiZnLec3uWenlv5ffggPFY-wky49fgYcDbwxViEdgf3f1S75W5siOvzF8dgvZlNOW
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MODULATION+OF+OXIDATIVE+STRESS+INDUCED+APOPTOSIS+AND+AUTOPHAGY+IN+CARDIOMYOCYTES+BY+INTERMEDIN&rft.jtitle=Heart+%28British+Cardiac+Society%29&rft.au=McCarthy%2C+C&rft.au=Zhao%2C+Y&rft.au=McKeag%2C+P&rft.au=Treggiari%2C+D&rft.date=2012-11-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=1355-6037&rft.eissn=1468-201X&rft.volume=98&rft.spage=A9&rft_id=info:doi/10.1136%2Fheartjnl-2012-303148a.29&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4021053341
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1355-6037&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1355-6037&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1355-6037&client=summon